supp.fit

Vitamin C, Zinc and Vitamin E: study protocols

20 study groups took Vitamin C together with Zinc and Vitamin E. These are the doses the studies gave. They are not a recommendation.

Vitamin C: what the research found →

Dose per serving from research: Vitamin C

20 study groups in 16 studies say how much Vitamin C participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 250 mg to 500 mg, 40% of 20 study groups.

Daily doseStudy groups
50 mg or less
1
50 mg to 100 mg
3
100 mg to 250 mg
7
250 mg to 500 mg
8
500 mg to 1 g
0
over 1 g
1

Dose per serving from research: Zinc

20 study groups in 16 studies say how much Zinc participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 10 mg to 25 mg, 45% of 20 study groups.

Daily doseStudy groups
2.5 mg to 5 mg
2
5 mg to 10 mg
1
10 mg to 25 mg
9
25 mg to 50 mg
1
50 mg to 100 mg
7

Dose per serving from research: Vitamin E

11 study groups in 11 studies say how much Vitamin E participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 25 mg to 50 mg, 45% of 11 study groups.

Daily doseStudy groups
1 mg to 2.5 mg
2
2.5 mg to 5 mg
0
5 mg to 10 mg
2
10 mg to 25 mg
2
25 mg to 50 mg
5

Commonly used together

20 of 20 study groups took Vitamin C, Zinc and Vitamin E with something else. Shown: what 3 or more different studies gave.

What was given together, not what works together.

Taken withStudy groups
Beta-Carotene
13
Copper
8
Selenium
8
Vitamin A
3

20 study groups

Study
Megadose vitamins in bladder cancer: a double-blind clinical trial
1994 · megadose vitamins arm · Patients with biopsy-confirmed transitional cell carcinoma of the bladder receiving BCG immunotherapy
2 g90 mg——35
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8
2001 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration Categories 2–4 and visual acuity of 20/32 or better in at least one eye
500 mg80 mg400 IU8 years—
Effects of maternal micronutrient supplementation on fetal loss and infant mortality: a cluster-randomized trial in Nepal
2003 · Multiple micronutrients · Pregnant women in rural Nepal
100 mg30 mg10 mg——
Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13
2004 · antioxidants plus zinc · Adults aged 55–81 years with AMD categories 2–4 and AREDS ocular eligibility
500 mg80 mg400 IU339 weeks—
The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals
2004 · antioxidant supplement group · French women aged 35–60 and men aged 45–60 in the general population
120 mg20 mg30 mg2739 days—
Antioxidant status and risk of cancer in the SU.VI.MAX study: is the effect of supplementation dependent on baseline levels?
2005 · daily antioxidant supplementation · French adults: women aged 35–60 years and men aged 45–60 years
120 mg20 mg30 mg2739 days—
Antioxidant supplementation increases the risk of skin cancers in women but not in men
2007 · antioxidant group · French adult women and men in a general-population primary-prevention trial
120 mg20 mg30 mg2738 days—
Long-term effects of vitamins C and E, β-carotene, and zinc on age-related macular degeneration: AREDS report no. 35
2013 · Antioxidants plus zinc · Adults aged 55–80 with age-related macular degeneration (AREDS categories 1–4)
500 mg80 mg400 IU339 weeks—
Micronutrient fortified milk improves iron status, anemia and growth among children 1-4 years: a double masked, randomized, controlled trial
2010 · Micronutrient-fortified milk (MN group) · Children aged 1–4 years in India; many had anemia, iron deficiency, or growth faltering
40.2 mg7.8 mg7.5 mg1 year316
A Collagen Supplement Improves Skin Hydration, Elasticity, Roughness, and Density: Results of a Randomized, Placebo-Controlled, Blind Study
2019 · verum group · Women aged 35–73 with healthy skin
80 mg3 mg2.3 mg12 weeks36